At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 129 enrolled
Drug / intervention
Bupivacaine Injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Effectiveness of Pre-incision Versus Post-incision Local Anesthetic During Laparoscopic/Robotic Sacrocolpopexy
In Brief
A Phase 4 clinical trial evaluating Bupivacaine Injection for Pain, Postoperative. Completed, enrolled 129 participants across 1 site.
Detailed Summary
Obtaining Likest-pain scale score on postoperative day one after injection of local anesthetic into incision sites of a laparoscopic/robotic-assisted sacrocolpopexy
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
Enrollment StartJul 2021
First PostedAug 2021
Primary CompletionMay 2023
Study CompletionJun 2023
TodayJul 2026
First PostedAug 9, 2021
Enrollment StartJul 30, 2021
Primary CompletionMay 30, 2023
Study CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.9 years ago
Interventions
Bupivacaine Injectiondrug
0.25% Bupivacaine being used as local anesthetic to inject into incision sites of tracer sites during a laparoscopic/robotic-assisted sacrocolpopexy